$5 PPS uplist scenario. For argument's sake, let's say PPS rises and holds at $5. When we uplist, the company could offer 20M new shares, which I believe would be gobbled up primarily by institutions and other strong hands. That would result in the company gaining $100M capital to fund expansion, with very little dilution impact. In fact, upon uplist we'd probably experience a rise in PPS. That is a win win scenario and a windfall for both the company and existing shareholders. I believe it's at least a possibility, if we can gain enough interest here. I believe RXMD is a UNICORN simply because that's possible; and I believe RXMD deserves that attention! I would certainly retire, just like our former CEO! Think about that fact.